<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(1)</volume><submitter>Shimoda TM</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Evidence is limited as to whether outcomes differ between patients with tricuspid regurgitation (TR) treated with tricuspid transcatheter edge-to-edge repair (T-TEER) versus surgical tricuspid valve repair. We aimed to compare outcomes between these 2 approaches.&lt;h4>Methods&lt;/h4>We analyzed the data on Medicare fee-for-service beneficiaries aged 65 to 99 years with TR who underwent T-TEER or isolated surgical repair between July 2016 and December 2020. The primary outcome was 2-year all-cause mortality. Other outcomes included in-hospital mortality and permanent pacemaker implantation as well as 2-year heart failure hospitalization and tricuspid valve reintervention. A propensity score matching weight analysis was used to adjust for potential confounders.&lt;h4>Results&lt;/h4>A</pubmed_abstract><journal>Circulation. Cardiovascular interventions</journal><pagination>e014825</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11748907</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Comparison of Transcatheter Versus Surgical Tricuspid Repair Among Patients With Tricuspid Regurgitation: Two-Year Results.</pubmed_title><pmcid>PMC11748907</pmcid><pubmed_authors>Kuno T</pubmed_authors><pubmed_authors>Takayama H</pubmed_authors><pubmed_authors>Elmariah S</pubmed_authors><pubmed_authors>Latib A</pubmed_authors><pubmed_authors>Watanabe A</pubmed_authors><pubmed_authors>Gotanda H</pubmed_authors><pubmed_authors>Kaneko T</pubmed_authors><pubmed_authors>Shimoda TM</pubmed_authors><pubmed_authors>Tsugawa Y</pubmed_authors><pubmed_authors>Kolte D</pubmed_authors><pubmed_authors>Ueyama HA</pubmed_authors><pubmed_authors>Miyamoto Y</pubmed_authors><pubmed_authors>Zajarias A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparison of Transcatheter Versus Surgical Tricuspid Repair Among Patients With Tricuspid Regurgitation: Two-Year Results.</name><description>&lt;h4>Background&lt;/h4>Evidence is limited as to whether outcomes differ between patients with tricuspid regurgitation (TR) treated with tricuspid transcatheter edge-to-edge repair (T-TEER) versus surgical tricuspid valve repair. We aimed to compare outcomes between these 2 approaches.&lt;h4>Methods&lt;/h4>We analyzed the data on Medicare fee-for-service beneficiaries aged 65 to 99 years with TR who underwent T-TEER or isolated surgical repair between July 2016 and December 2020. The primary outcome was 2-year all-cause mortality. Other outcomes included in-hospital mortality and permanent pacemaker implantation as well as 2-year heart failure hospitalization and tricuspid valve reintervention. A propensity score matching weight analysis was used to adjust for potential confounders.&lt;h4>Results&lt;/h4>A</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-03T23:36:48.526Z</modification><creation>2025-04-03T23:36:48.526Z</creation></dates><accession>S-EPMC11748907</accession><cross_references><pubmed>39556351</pubmed><doi>10.1161/circinterventions.124.014825</doi><doi>10.1161/CIRCINTERVENTIONS.124.014825</doi></cross_references></HashMap>